[Pathogenesis, diagnostics and therapy of gout]

Area of Science:

• Rheumatology
• Nephrology
• Metabolic Diseases

Context:

• Gout is a common inflammatory joint disease, particularly in men over 50.
• It involves sodium urate crystal deposition, causing acute arthritis, chronic arthropathy (tophi), and kidney complications (nephropathy, urolithiasis).
• Hyperuricemia, often due to impaired renal secretion, is a key feature and linked to metabolic syndrome X.

Purpose:

• To elucidate the multifaceted nature of gout, encompassing its clinical manifestations, underlying pathophysiology, and diagnostic considerations.
• To highlight the inadequate diagnosis and treatment of gouty arthritis.
• To establish criteria for initiating long-term hypouricemic therapy.

Summary:

• Gout involves urate crystal deposits causing arthritis and kidney problems.
• Hyperuricemia in gout is primarily due to reduced uric acid excretion.
• Inflammation triggered by urate crystals is central to gouty arthritis pathogenesis.
• Gout is linked to metabolic syndrome X, with ongoing research into uric acid's role in atherosclerosis.

Impact:

• Emphasizes the need for comprehensive gout evaluation, including renal assessment and exclusion of secondary hyperuricemia.
• Stresses the importance of considering associated metabolic syndrome X conditions.
• Provides guidelines for appropriate patient selection for hypouricemic therapy, aiming for improved patient outcomes.